RELM b Human

RELM-Beta Human Recombinant
Cat. No.
BT20396
Source
Escherichia Coli.
Synonyms
Resistin-like beta, RELM beta, Cysteine-rich secreted protein FIZZ2, Colon and small intestine-specific cysteine-rich protein, Cysteine-rich secreted protein A12-alpha-like 1, Colon carcinoma-related gene protein, RELM-b, XCP2, HXCP2.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

RELM-b Human Recombinant produced in E.Coli is a disulfide-linked homodimer, non-glycosylated, polypeptide chain containing 2 x 89 amino acids and having a total molecular mass of 19kDa.
RELM-b is purified by proprietary chromatographic techniques.

Product Specs

Introduction
RELM-beta, or Resistin-Like Molecule-beta, belongs to a newly discovered family of secreted proteins characterized by a conserved cysteine-rich C-terminus. This family includes resistin (also known as FIZZ3), RELM-alpha (FIZZ1), RELM-beta (FIZZ2), and RELM-gamma. While humans only possess resistin and RELM-beta, all four members are present in rodents. RELM-beta is primarily produced as a homodimer by intestinal goblet cells and is abundant in stool. Interestingly, RELM-beta is absent in the stool of germ-free mice with sterile intestinal tracts until they are exposed to bacteria in a natural environment. A subset of colon carcinoma cell lines has been observed to secrete RELM-beta into the cell culture supernatant. Currently, the physiological function of RELM-beta remains unclear. However, studies in mice have shown that high doses of recombinant RELM-beta can induce hyperglycemic effects, including reduced glucose disposal and increased hepatic glucose production.
Description
Recombinant Human RELM-b, produced in E. coli, is a non-glycosylated, disulfide-linked homodimer. Each polypeptide chain consists of 89 amino acids, resulting in a total molecular mass of 19 kDa. The purification of RELM-b is achieved using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized powder.
Formulation
RELM-b is lyophilized in a solution of 0.1% Trifluoroacetic Acid (TFA).
Solubility
To reconstitute lyophilized RELM-b, it is recommended to dissolve it in sterile 0.1% TFA at a minimum concentration of 100 µg/ml. This solution can then be further diluted in other aqueous solutions as needed.
Stability
Lyophilized RELM-b remains stable at room temperature for up to 3 weeks; however, for long-term storage, it should be stored desiccated at a temperature below -18°C. Once reconstituted, Human Recombinant RELM-b should be stored at 4°C for 2-7 days. For extended storage, it is advisable to store it below -18°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
The purity of RELM-b is determined to be greater than 90.0% using SDS-PAGE analysis.
Synonyms
Resistin-like beta, RELM beta, Cysteine-rich secreted protein FIZZ2, Colon and small intestine-specific cysteine-rich protein, Cysteine-rich secreted protein A12-alpha-like 1, Colon carcinoma-related gene protein, RELM-b, XCP2, HXCP2.
Source
Escherichia Coli.
Amino Acid Sequence
MQCSLDSVMD KKIKDVLNSL EYSPSPISKK LSCASVKSQG RPSSCPAGMA VTGCACGYGC GSWDVQLETT CHCQCSVVDW TTARCCHLT.

Product Science Overview

Structure and Characteristics

RELM-β is a non-glycosylated, disulfide-linked homodimer. Each monomer consists of 89 amino acids, resulting in a total molecular weight of approximately 19 kDa for the dimer . The protein is characterized by conserved cysteines in its C-terminus, which are crucial for its structural integrity and function .

Expression and Function

RELM-β is predominantly expressed in the gastrointestinal tract, particularly in the colon. Its expression is highest in proliferative epithelial cells and is significantly increased in tumors, suggesting a role in intestinal proliferation . The secretion of RELM-β by intestinal goblet cells is induced by Th2 cytokines in response to nematode infections .

Biological Activity

While the exact biological functions of RELM-β are still being investigated, it is known to be involved in various physiological and pathological processes. Its expression in the gastrointestinal tract and its upregulation in tumors indicate a potential role in intestinal health and disease .

Recombinant Production

Recombinant human RELM-β is produced using Escherichia coli (E. coli) expression systems. The recombinant protein is typically lyophilized and can be reconstituted with sterile water for research applications . It is important to handle the reconstituted protein with care, as it is recommended to add a carrier protein (such as 0.1% HSA or BSA) for long-term storage .

Applications

RELM-β is used primarily in research settings to study its role in gastrointestinal health, inflammation, and cancer. It is not intended for human, animal, or diagnostic applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.